These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 15535974)
1. Fucoxanthin induces apoptosis and enhances the antiproliferative effect of the PPARgamma ligand, troglitazone, on colon cancer cells. Hosokawa M; Kudo M; Maeda H; Kohno H; Tanaka T; Miyashita K Biochim Biophys Acta; 2004 Nov; 1675(1-3):113-9. PubMed ID: 15535974 [TBL] [Abstract][Full Text] [Related]
2. Troglitazone and 9cis,11trans,13trans-conjugated linolenic acid: comparison of their antiproliferative and apoptosis-inducing effects on different colon cancer cell lines. Yasui Y; Hosokawa M; Kohno H; Tanaka T; Miyashita K Chemotherapy; 2006; 52(5):220-5. PubMed ID: 16899971 [TBL] [Abstract][Full Text] [Related]
3. Troglitazone Enhances the Apoptotic Response of DLD-1 Colon Cancer Cells to Photodynamic Therapy. Park H; Ko SH; Lee JM; Park JH; Choi YH Yonsei Med J; 2016 Nov; 57(6):1494-9. PubMed ID: 27593880 [TBL] [Abstract][Full Text] [Related]
4. Down-regulation of X-linked inhibitor of apoptosis synergistically enhanced peroxisome proliferator-activated receptor gamma ligand-induced growth inhibition in colon cancer. Qiao L; Dai Y; Gu Q; Chan KW; Zou B; Ma J; Wang J; Lan HY; Wong BC Mol Cancer Ther; 2008 Jul; 7(7):2203-11. PubMed ID: 18645029 [TBL] [Abstract][Full Text] [Related]
5. Induction of G1 phase arrest and apoptosis in MDA-MB-231 breast cancer cells by troglitazone, a synthetic peroxisome proliferator-activated receptor gamma (PPARgamma) ligand. Yu HN; Lee YR; Noh EM; Lee KS; Kim JS; Song EK; Han MK; Lee YC; Kwon KB; Lee SJ; Youn HJ; Jung SH Cell Biol Int; 2008 Aug; 32(8):906-12. PubMed ID: 18474441 [TBL] [Abstract][Full Text] [Related]
6. [Effects of peroxisome proliferator-activated receptor-gamma ligand troglitazone on colon cancer cell growth]. Koirala K; Wan YL; Liu YC; Wang X; Cui W; Wang CL; Chen HN; Wang HY; Zhu J Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Aug; 38(4):385-8. PubMed ID: 16892143 [TBL] [Abstract][Full Text] [Related]
7. A ligand for peroxisome proliferator activated receptor gamma inhibits cell growth and induces apoptosis in human liver cancer cells. Toyoda M; Takagi H; Horiguchi N; Kakizaki S; Sato K; Takayama H; Mori M Gut; 2002 Apr; 50(4):563-7. PubMed ID: 11889080 [TBL] [Abstract][Full Text] [Related]
8. Loss of XIAP sensitizes colon cancer cells to PPARgamma independent antitumor effects of troglitazone and 15-PGJ2. Qiao L; Dai Y; Gu Q; Chan KW; Ma J; Lan HY; Zou B; Rocken C; Ebert MP; Wong BC Cancer Lett; 2008 Sep; 268(2):260-71. PubMed ID: 18477501 [TBL] [Abstract][Full Text] [Related]
9. The peroxisome proliferator-activated receptor gamma ligand troglitazone induces apoptosis and p53 in rat granulosa cells. Lovekamp-Swan T; Chaffin CL Mol Cell Endocrinol; 2005 Apr; 233(1-2):15-24. PubMed ID: 15767042 [TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptor gamma ligands induce cell cycle arrest and apoptosis in human renal carcinoma cell lines. Yang FG; Zhang ZW; Xin DQ; Shi CJ; Wu JP; Guo YL; Guan YF Acta Pharmacol Sin; 2005 Jun; 26(6):753-61. PubMed ID: 15916743 [TBL] [Abstract][Full Text] [Related]
12. A peroxisome proliferator-activated receptor-gamma agonist, troglitazone, facilitates caspase-8 and -9 activities by increasing the enzymatic activity of protein-tyrosine phosphatase-1B on human glioma cells. Akasaki Y; Liu G; Matundan HH; Ng H; Yuan X; Zeng Z; Black KL; Yu JS J Biol Chem; 2006 Mar; 281(10):6165-74. PubMed ID: 16319070 [TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo cytotoxicity of troglitazone in pancreatic cancer. Fujita M; Hasegawa A; Yamamori M; Okamura N J Exp Clin Cancer Res; 2017 Jul; 36(1):91. PubMed ID: 28673319 [TBL] [Abstract][Full Text] [Related]
14. Activation of peroxisome proliferator-activated receptor-gamma by troglitazone (TGZ) inhibits human lung cell growth. Li M; Lee TW; Mok TS; Warner TD; Yim AP; Chen GG J Cell Biochem; 2005 Nov; 96(4):760-74. PubMed ID: 16149072 [TBL] [Abstract][Full Text] [Related]
15. Fucoxanthin induces cell cycle arrest at G0/G1 phase in human colon carcinoma cells through up-regulation of p21WAF1/Cip1. Das SK; Hashimoto T; Shimizu K; Yoshida T; Sakai T; Sowa Y; Komoto A; Kanazawa K Biochim Biophys Acta; 2005 Nov; 1726(3):328-35. PubMed ID: 16236452 [TBL] [Abstract][Full Text] [Related]
16. Troglitazone inhibits cell growth and induces apoptosis of B-cell acute lymphoblastic leukemia cells with t(14;18). Takenokuchi M; Saigo K; Nakamachi Y; Kawano S; Hashimoto M; Fujioka T; Koizumi T; Tatsumi E; Kumagai S Acta Haematol; 2006; 116(1):30-40. PubMed ID: 16809887 [TBL] [Abstract][Full Text] [Related]
17. Suppression of NF-kappaB and GSK-3beta is involved in colon cancer cell growth inhibition by the PPAR agonist troglitazone. Ban JO; Kwak DH; Oh JH; Park EJ; Cho MC; Song HS; Song MJ; Han SB; Moon DC; Kang KW; Hong JT Chem Biol Interact; 2010 Oct; 188(1):75-85. PubMed ID: 20540935 [TBL] [Abstract][Full Text] [Related]
18. A Ligand for peroxisome proliferator-activated receptor gamma inhibits human cholangiocarcinoma cell growth: potential molecular targeting strategy for cholangioma. Kobuke T; Tazuma S; Hyogo H; Chayama K Dig Dis Sci; 2006 Sep; 51(9):1650-7. PubMed ID: 16927143 [TBL] [Abstract][Full Text] [Related]
19. Troglitazone, a peroxisome proliferator-activated receptor gamma ligand, induces growth inhibition and apoptosis of HepG2 human liver cancer cells. Zhou YM; Wen YH; Kang XY; Qian HH; Yang JM; Yin ZF World J Gastroenterol; 2008 Apr; 14(14):2168-73. PubMed ID: 18407589 [TBL] [Abstract][Full Text] [Related]
20. [Troglitazone sensitizes effect of epirubicin on breast cancer cells]. Sun JX; Meng ZX; Lv JH; Sun YJ Ai Zheng; 2006 Aug; 25(8):960-6. PubMed ID: 16965675 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]